Ze Hua Zhao
Direttore Finanziario/CFO presso UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED
Posizioni attive di Ze Hua Zhao
Società | Posizione | Inizio | Fine |
---|---|---|---|
UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED | Direttore Finanziario/CFO | 01/10/2011 | - |
Direttore/Membro del Consiglio | 16/06/2015 | - | |
Comptroller/Controller/Auditor | 01/01/2005 | 01/10/2011 |
Storia della carriera di Ze Hua Zhao
Precedenti posizioni note di Ze Hua Zhao
Società | Posizione | Inizio | Fine |
---|---|---|---|
Chengde Tianyuan Pharmaceutical Industry Co., Ltd.
Chengde Tianyuan Pharmaceutical Industry Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Goldenmax International Group Ltd., Chengde Tianyuan Pharmaceutical Industry Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical preparations. The company is based in Chengde, China. Chengde Tianyuan Pharmaceutical Industry Co. was acquired by Goldenmax International Group Ltd. on October 23, 2019 for $26.17 million. | Direttore Finanziario/CFO | 01/08/1989 | 01/12/2004 |
Formazione di Ze Hua Zhao
Hebei Radio & TV University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Cina | 4 |
Posizioni
Director of Finance/CFO | 2 |
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Settori
Retail Trade | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED | Retail Trade |
Aziende private | 1 |
---|---|
Chengde Tianyuan Pharmaceutical Industry Co., Ltd.
Chengde Tianyuan Pharmaceutical Industry Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Goldenmax International Group Ltd., Chengde Tianyuan Pharmaceutical Industry Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical preparations. The company is based in Chengde, China. Chengde Tianyuan Pharmaceutical Industry Co. was acquired by Goldenmax International Group Ltd. on October 23, 2019 for $26.17 million. | Health Technology |
- Borsa valori
- Insiders
- Ze Hua Zhao
- Esperienza